Liquid segment of the Antacid Market to Grow at Fastest CAGR during Forecast Period.
According to the new market research study on “Antacid Market Forecast to 2027 - COVID-19 Impact and Global Analysis - by Dosage Form, Drug Class And Distribution Channel,” the market is expected to reach US$ 11,666.83 million in 2027 from US$ 8,547.97 million in 2019. The market is estimated to grow with a CAGR of 4.0% from 2020-2027. The report highlights trends prevailing in the global Antacid market, and the drivers and restraints pertaining to the market growth.
Based on dosage form, the antacid market is segmented into tablet, liquid, and others. In 2019, the microbial tablet segment held the largest share of the market. The liquid segment is expected to grow at the fastest rate during the forecast period. liquid dosage form is preferred by children and ageing population due to its flavored/palatable taste. Also, presence of major market players such as Procter & Gamble, Pfizer, GSK GROUP and others are offering liquid antacids which is likely to propel the growth of the segment.
The global antacid market growth is mainly attributed to factors such as rising prevalence of healthcare-associated infections and increasing emphasis on food safety. However, limitations of ATP swab tests hinder the market growth.
Sanofi, GlaxoSmithKline plc, Bayer AG, Takeda Pharmaceutical Company Limited, Sun Pharmaceuticals Ltd, Boehringer Ingelheim International Gmbh, Dr. Reddy’s Laboratories Ltd., Pfizer, Inc, Reckitt Benckiser Group Plc., and Procter And Gamble are among the leading companies operating in the antacid market.
The report segments global Antacid market as follows:
By Dosage Form
By Drug class
By Distribution Channel
By Geography
Reasons to Buy:
According to the new market research study on “Antacid Market Forecast to 2027 - COVID-19 Impact and Global Analysis - by Dosage Form, Drug Class And Distribution Channel,” the market is expected to reach US$ 11,666.83 million in 2027 from US$ 8,547.97 million in 2019. The market is estimated to grow with a CAGR of 4.0% from 2020-2027. The report highlights trends prevailing in the global Antacid market, and the drivers and restraints pertaining to the market growth.
Based on dosage form, the antacid market is segmented into tablet, liquid, and others. In 2019, the microbial tablet segment held the largest share of the market. The liquid segment is expected to grow at the fastest rate during the forecast period. liquid dosage form is preferred by children and ageing population due to its flavored/palatable taste. Also, presence of major market players such as Procter & Gamble, Pfizer, GSK GROUP and others are offering liquid antacids which is likely to propel the growth of the segment.
The global antacid market growth is mainly attributed to factors such as rising prevalence of healthcare-associated infections and increasing emphasis on food safety. However, limitations of ATP swab tests hinder the market growth.
Sanofi, GlaxoSmithKline plc, Bayer AG, Takeda Pharmaceutical Company Limited, Sun Pharmaceuticals Ltd, Boehringer Ingelheim International Gmbh, Dr. Reddy’s Laboratories Ltd., Pfizer, Inc, Reckitt Benckiser Group Plc., and Procter And Gamble are among the leading companies operating in the antacid market.
The report segments global Antacid market as follows:
By Dosage Form
- Tablet
- Liquid
- Others
By Drug class
- Proton pump inhibitors
- H2 Antagonist
- Acid neutralizers
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South America
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the antacid market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global antacid market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Antacid Market - By Dosage Form
1.3.2 Antacid Market - By Drug Class
1.3.3 Antacid Market - By Distribution Channel
1.3.4 Global Antacid Market - By Geography
2. Antacid Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Antacids - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions
5. Antacid Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Gastroesophageal Reflux Disease (GERD)
5.1.2 Increase in Prevalence of Obesity
5.2 Market Restraints
5.2.1 Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies
5.3 Market Opportunities
5.3.1 Increasing Research Activities and Research Funds on GI Disorders
5.4 Future Trends
5.4.1 Development and Launch of Innovative Products
5.5 Impact Analysis
6. Antacid Market - Global Analysis
6.1 Global Antacid Market Revenue Forecast And Analysis
6.2 Global Antacid Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Antacid Market Analysis - By Dosage Form
7.1 Overview
7.2 Antacid Market Revenue Share, by Dosage Form (2019 and 2027)
7.3 Tablet
7.3.1 Overview
7.3.2 Tablet: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Liquid
7.4.1 Overview
7.4.2 Liquid: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
8. Antacid Market Analysis - By Drug Class
8.1 Overview
8.2 Antacid Market Revenue Share, by Drug Class (2019 and 2027)
8.3 Proton Pump Inhibitors
8.3.1 Overview
8.3.2 Proton Pump Inhibitors: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
8.4 H₂ Antagonist
8.4.1 Overview
8.4.2 H₂ Antagonist: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Acid Neutralizers
8.5.1 Overview
8.5.2 Acid Neutralizers: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
8.5.3 Magaldrate
8.5.3.1 Overview
8.5.3.2 Magaldrate: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
8.5.4 Sucralfate
8.5.4.1 Overview
8.5.4.2 Sucralfate: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
8.5.5 Others
8.5.5.1 Overview
8.5.5.2 Others: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
9. Antacid Market Analysis - By Distribution Channel
9.1 Overview
9.2 Antacid Market Share, by Distribution Channel, 2019 and 2027, (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
10. Antacid Market - Geographic Analysis
10.1 North America: Antacid Market
10.1.1 Overview
10.1.2 North America: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
10.1.4 North America: Antacid Market, by Drug Class, 2018-2027 (USD Million)
10.1.4.1 North America: Acid Neutralizers Market, by Type, 2018-2027 (USD Million)
10.1.5 North America: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
10.1.6 North America: Antacid Market, by Country, 2019 & 2027 (%)
10.1.7 US: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
10.1.7.3 US: Antacid Market, by Drug Class 2018-2027 (USD Million)
10.1.7.3.1 US: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
10.1.7.4 US: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
10.1.8 Canada: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
10.1.8.3 Canada: Antacid Market, by Drug Class 2018-2027 (USD Million)
10.1.8.3.1 Canada: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
10.1.8.4 Canada: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
10.1.9 Mexico: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
10.1.9.3 Mexico: Antacid Market, by Drug Class 2018-2027 (USD Million)
10.1.9.3.1 Mexico: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
10.1.9.4 Mexico: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
10.2 Europe: Antacid Market
10.2.1 Overview
10.2.2 Europe: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
10.2.4 Europe: Antacid Market, by Drug Class 2018-2027 (USD Million)
10.2.4.1 Europe: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
10.2.5 Europe: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
10.2.6 Europe: Antacid Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
10.2.7.3 Germany: Antacid Market, by Drug Class 2018-2027 (USD Million)
10.2.7.3.1 Germany: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
10.2.7.4 Germany: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
10.2.8 UK: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
10.2.8.3 UK: Antacid Market, by Drug Class 2018-2027 (USD Million)
10.2.8.3.1 UK: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
10.2.8.4 UK: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
10.2.9 France: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
10.2.9.3 France: Antacid Market, by Drug Class 2018-2027 (USD Million)
10.2.9.3.1 France: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
10.2.9.4 France: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
10.2.10 Spain: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
10.2.10.3 Spain: Antacid Market, by Drug Class 2018-2027 (USD Million)
10.2.10.3.1 Spain: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
10.2.10.4 Spain: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
10.2.11 Italy: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
10.2.11.3 Italy: Antacid Market, by Drug Class 2018-2027 (USD Million)
10.2.11.3.1 Italy: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
10.2.11.4 Italy: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
10.2.12 Rest of Europe: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.2.12.1 Rest of Europe: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.2.12.2 Rest of Europe: Antacid Market, by Dosage Form, 2018-2027 (USD Million)
10.2.12.3 Rest of Europe: Antacid Market, by Drug Class 2018-2027 (USD Million)
10.2.12.3.1 Rest of Europe: Acid Neutralizers Market, by Type 2018-2027 (USD Million)
10.2.12.4 Rest of Europe: Antacid Market, by Distribution Channel, 2018-2027 (USD Million)
10.3 Asia-Pacific: Antacid Market
10.3.1 Overview
10.3.2 Asia-Pacific: Antacid Market, - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia-Pacific: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.3.4 Asia-Pacific: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.3.4.1 Asia-Pacific: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
10.3.5 Asia-Pacific: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.6 Asia-Pacific: Antacid Market, by Country, 2019 & 2027 (%)
10.3.7 China: Antacid Market, - Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Antacid Market, - Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.3.7.3 China: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.3.7.3.1 China: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
10.3.7.4 China: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.8 Japan: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.3.8.3 Japan: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.3.8.3.1 Japan: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
10.3.8.4 Japan: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.9 India: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.3.9.3 India: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.3.9.4 India: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
10.3.9.5 India: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.10 South Korea: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.3.10.3 South Korea: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.3.10.3.1 South Korea: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
10.3.10.4 South Korea: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.11 Australia: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.3.11.3 Australia: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.3.11.3.1 Australia: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
10.3.11.4 Australia: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.3.12 Rest of Asia Pacific: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.3.12.1 Rest of Asia Pacific: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.3.12.2 Rest of Asia Pacific: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.3.12.3 Rest of Asia Pacific: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.3.12.4 Rest of Asia Pacific: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
10.3.12.5 Rest of Asia Pacific: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4 Middle East & Africa: Antacid Market
10.4.1 Overview
10.4.2 Middle East & Africa: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.4.4 Middle East & Africa: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.4.4.1 Middle East & Africa: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
10.4.5 Middle East & Africa: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4.6 Middle East & Africa: Antacid Market, by Country, 2019 & 2027 (%)
10.4.7 Saudi Arabia: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.4.7.3 Saudi Arabia: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.4.7.3.1 Saudi Arabia: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
10.4.7.4 Saudi Arabia: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4.8 UAE: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.4.8.3 UAE: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.4.8.4 UAE: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
10.4.8.5 UAE: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4.9 South Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.4.9.3 South Africa: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.4.9.4 Asia-Pacific: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
10.4.9.5 South Africa: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.4.10 Rest of Middle East and Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.4.10.1 Rest of Middle East and Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.4.10.2 Rest of Middle East and Africa: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.4.10.3 Rest of Middle East and Africa: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.4.10.4 Asia-Pacific: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
10.4.10.5 Rest of Middle East and Africa: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.5 South and Central America: Antacid Market
10.5.1 Overview
10.5.2 South and Central America: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.5.3 South and Central America: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.5.4 South and Central America: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.5.4.1 South and Central America: Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.5 South and Central America: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.5.6 South and Central America: Antacid Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.5.7.3 Brazil: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.5.7.3.1 Brazil: Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.7.4 Brazil: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.5.8 Argentina: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
10.5.8.3 Argentina: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.5.8.3.1 Argentina: Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.8.4 Argentina: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
10.5.9 Rest of South and Central America: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.5.9.1 Rest of South and Central America: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.5.9.2 Rest of South and Central America: Antacid Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
10.5.9.3 Rest of South and Central America: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
10.5.9.3.1 Rest of South and Central America: Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
10.5.9.4 Rest of South and Central America: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Antacid Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Antacid Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Bayer AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Takeda Pharmaceutical Company Limited
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sun Pharmaceutical Industries Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sanofi
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Boehringer Ingelheim International GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Dr. Reddy's Laboratories
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Pfizer Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 roducts and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Reckitt Benckiser Group Plc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Procter & Gamble
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 Glossary of TermsList of Tables
Table 1. North America Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 2. North America Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 3. North America Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 4. North America Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 5. US Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 6. US Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 7. US Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 8. US Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 12. Canada Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 17. Europe Antacid Market, by Dosage Form- Revenue and Forecast to 2027 (USD Million)
Table 18. Europe Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 19. Europe Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 20. Europe Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 21. Germany Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 22. Germany Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 23. Germany Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 24. Germany Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 25. UK Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 26. UK Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 27. UK Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 28. UK Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 29. France Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 30. France Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 31. France Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 32. France Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 33. Spain Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 34. Spain Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 35. Spain Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 36. Spain Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 37. Italy Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 38. Italy Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 39. Italy Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 40. Italy Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 41. Rest of Europe Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 42. Rest of Europe Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 43. Rest of Europe Acid Neutralizers Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 44. Rest of Europe Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 45. Asia-Pacific: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 46. Asia-Pacific: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 47. Asia-Pacific: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
Table 48. Asia-Pacific: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 49. China: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 50. China: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 51. China: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
Table 52. China: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 53. Japan: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 54. Japan: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 55. Japan: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
Table 56. Japan: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 57. India: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 58. India: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 59. India: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
Table 60. India: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 61. South Korea: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 62. South Korea: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 63. South Korea: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
Table 64. South Korea: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 65. Australia: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 66. Australia: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 67. Australia: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
Table 68. Australia: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 69. Rest of Asia Pacific: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 70. Rest of Asia Pacific: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 71. Rest of Asia Pacific: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
Table 72. Rest of Asia Pacific: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 73. Middle East & Africa: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 74. Middle East & Africa: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 75. Middle East & Africa: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
Table 76. Middle East & Africa: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 77. Saudi Arabia: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 78. Saudi Arabia: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 79. Saudi Arabia: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
Table 80. Saudi Arabia: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 81. UAE: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 82. UAE: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 83. UAE: Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
Table 84. UAE: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 85. South Africa: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 86. South Africa: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 87. South Africa Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
Table 88. South Africa: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 89. Rest of Middle East and Africa: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 90. Rest of Middle East and Africa: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 91. Rest of Middle East and Africa Antacid Market, by Acid Neutralizers - Revenue and Forecast to 2027 (USD Million)
Table 92. Rest of Middle East and Africa: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 93. South and Central America: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 94. South and Central America: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 95. South and Central America: Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 96. South and Central America: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 97. Brazil: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 98. Brazil: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 99. Brazil: Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 100. Brazil: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 101. Argentina: Antacid Market, by Dosage Form - Revenue and Forecast to 2027 (USD Million)
Table 102. Argentina: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 103. Argentina: Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 104. Argentina: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 105. Rest of South and Central America: Antacid Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
Table 106. Rest of South and Central America: Antacid Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 107. Rest of South and Central America: Acid Neutralizers Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 108. Rest of South and Central America: Antacid Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 109. Organic Developments Done By Companies
Table 110. Inorganic Developments Done By Companies
Table 111. Glossary of Terms, Antacid MarketList of Figures
Figure 1. Antacid Market Segmentation
Figure 2. Antacid Market - By Geography
Figure 3. Antacid Market Overview
Figure 4. Liquid to Witness Rapid Growth of Antacid Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Antacid Market, by Geography (US$ Million)
Figure 7. Global Antacid Market - Leading Country Markets (US$ Million)
Figure 8. Global Antacid Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Antacid Market Impact Analysis of Drivers and Restraints
Figure 15. Global Antacid Market - Revenue Forecast And Analysis - 2019- 2027
Figure 16. Global Antacid Market - By Geography Forecast and Analysis - 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Antacid Market
Figure 18. Antacid Market Revenue Share, by Dosage Form (2019 and 2027)
Figure 19. Tablet: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Liquid: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Others: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Antacid Market Revenue Share, by Drug Class (2019 and 2027)
Figure 23. Proton Pump Inhibitors: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. H₂ Antagonist: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Acid Neutralizers: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Magaldrate: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Sucralfate: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 28. Others: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 29. Antacid Market Share, by Distribution Channel, 2019 and 2027 (%)
Figure 30. Hospital Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 31. Retail Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 32. Online Pharmacy: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
Figure 33. North America: Antacid Market, by Key Country - Revenue (2019) (USD Million)
Figure 34. North America Antacid Market Revenue and Forecast to 2027 (USD Million)
Figure 35. North America: Antacid Market, by Country, 2019 & 2027 (%)
Figure 36. US: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 37. Canada: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 38. Mexico: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 39. Europe: Antacid Market, by Key Country - Revenue (2019) (USD Million)
Figure 40. Europe Antacid Market Revenue and Forecast to 2027 (USD Million)
Figure 41. Europe: Antacid Market, by Country, 2019 & 2027 (%)
Figure 42. Germany: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 43. UK: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 44. France: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 45. Spain: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 46. Italy: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 47. Rest of Europe: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 48. Asia-Pacific: Antacid Market, by Key Country - Revenue (2019) (USD Million)
Figure 49. Asia-Pacific: Antacid Market, Revenue and Forecast to 2027 (USD Million)
Figure 50. Asia-Pacific: Antacid Market, by Country, 2019 & 2027 (%)
Figure 51. China: Antacid Market, - Revenue and Forecast to 2027 (USD Million)
Figure 52. Japan Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 53. India: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 54. South Korea: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 55. Australia: Antacid - Revenue and Forecast to 2027 (USD Million)
Figure 56. Rest of Asia Pacific: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 57. Middle East & Africa: Antacid Market, by Key Country - Revenue (2019) (USD Million)
Figure 58. Middle East & Africa Antacid Market -Revenue and Forecast to 2027 (USD Million)
Figure 59. Middle East & Africa: Antacid Market, by Country, 2019 & 2027 (%)
Figure 60. Saudi Arabia: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 61. UAE: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 62. South Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 63. Rest of Middle East and Africa: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 64. South and Central America: Antacid Market , by Key Country - Revenue (2019) (USD Million)
Figure 65. South and Central America: Antacid Market, Revenue and Forecast to 2027 (USD Million)
Figure 66. South and Central America: Antacid Market, by Country, 2019 & 2027 (%)
Figure 67. Brazil: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 68. Argentina: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 69. Rest of South and Central America: Antacid Market - Revenue and Forecast to 2027 (USD Million)
Figure 70. Impact of COVID-19 Pandemic on Antacid Market in North American Countries
Figure 71. Impact of COVID-19 Pandemic on Antacid Market in European Countries
Figure 72. Impact of COVID-19 Pandemic on Antacid Market in Asia Pacific Countries
Figure 73. Impact of COVID-19 Pandemic on Antacid Market in Rest of the World
Figure 74. Growth Strategies Done by the Companies in the Market
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer AG
- GlaxoSmithKline plc.
- Takeda Pharmaceutical Company Limited
- Sun Pharmaceutical Industries Ltd
- Sanofi
- Boehringer Ingelheim International GmbH
- Dr. Reddy's Laboratories
- Pfizer Inc.
- Reckitt Benckiser Group Plc
- Procter & Gamble
